Purple Biotech PPBT Cash Flow Statement (2014-2026)

NASDAQ PPBT
$1.80 -0.04 (-2.19%)
As of: Sep 10, 2026 · 1:06 PM EDT
Reported Financials

Purple Biotech Quarterly Cash Flow Statement

Periods 30 quarters
Latest Jun 2026

Purple Biotech reported cash from operations of -$2.50M and free cash flow of -$2.50M for the quarter ended Jun 2026, down 62.1% year over year. This cash flow statement covers 30 quarters of results from Sep 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2014 Dec2014 Sep2015 Dec2015 Dec2017 Dec2018 Dec2019 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
0.15M0.51M-7.32M-3.55M-4.85M-4.90M-5.16M-5.05M-3.78M-2.42M-0.67M-0.46M-1.09M-1.30M-0.09M
Depreciation and Depletion
0.06M0.12M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.04M0.04M0.05M0.06M0.05M0.07M0.07M
Share-based Compensation
0.39M0.70M0.31M0.56M0.71M0.84M0.75M0.49M0.45M0.18M0.27M0.22M0.13M-0.03M0.09M0.06M0.20M-0.04M0.09M0.07M
Cash from Discontinued Operations
-0.03M-0.37M
Gains from Investment Securities
Cash from Operations
-2.91M-6.88M-5.20M-3.70M-3.62M-4.21M-6.06M-5.22M-3.66M-4.98M-5.08M-3.98M-3.29M-2.01M-1.98M-1.54M-1.07M-1.07M-3.12M-2.50M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization
0.06M0.12M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.04M0.04M0.05M0.06M0.05M0.07M0.07M
Change in Working Capital
Change in Account Payables
-0.14M1.20M2.73M-2.82M1.62M1.64M-1.50M0.87M1.04M0.18M-0.67M0.18M-1.14M-0.45M0.13M-0.95M-0.02M1.29M0.30M-2.04M
Change in Accured Expenses
-0.04M-0.08M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.05M-0.04M-0.05M-0.05M-0.04M-0.06M-0.06M-0.06M-0.07M
Investing Activities
Capital Expenditures
-0.01M-0.01M-0.01M-0.01M-0.01M-0.00M-0.00M0.00M
Acquisitions
-3.55M
Change in Acquisitions & Divestments
0.19M0.22M0.07M0.32M-0.15M
Cash from Investing Activities
1.57M6.63M17.72M-5.98M0.18M8.00M12.60M0.20M1.01M0.07M0.31M0.09M0.07M0.04M0.26M0.11M0.37M-0.10M0.04M0.00M
Financing Activities
Other financing activities
6.40M-2.50M0.02M0.00M8.00M-0.01M-0.00M-0.01M0.01M
Debt Issuance and Repayment
Long-Term Debt Issuances
Short-Term Debt issuances
20.30M-6.00M15.80M0.00M0.00M-0.01M-0.00M0.00M0.00M
Change in Capital Stock
Net Equity Issued and Repurchased
Misc.
Cash from Financing Activities
-0.06M0.48M0.16M0.29M0.57M0.09M0.26M0.37M0.57M4.25M0.27M0.43M2.13M3.94M0.10M0.37M5.57M0.30M-0.06M2.12M
Exchange Rate Effect
-0.00M-0.01M-0.03M-0.15M-0.06M0.08M0.05M-0.02M-0.02M0.05M-0.00M-0.01M0.00M-0.01M0.04M-0.02M-0.00M-0.01M0.05M
Change in Cash
-1.42M1.78M12.68M-9.38M-2.88M3.87M6.80M-4.66M-2.08M-0.66M-4.50M-3.46M-1.09M1.96M-1.62M-1.07M4.87M-0.87M-3.14M-0.38M
Free Cash Flow
-2.90M-6.87M-5.19M-3.69M-3.62M-4.21M-6.06M-5.22M-3.66M-4.98M-5.08M-3.98M-3.29M-2.01M-1.98M-1.54M-1.07M-1.07M-3.12M-2.50M
Net Cash Flow
-1.39M0.23M12.68M-9.38M-2.88M3.87M6.80M-4.66M-2.08M-0.66M-4.50M-3.46M-1.09M1.96M-1.62M-1.07M4.87M-0.87M-3.14M-0.38M